BioPharm International, December 2011 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, December 2011
Features
The Employment Outlook Brightens
By Amy Ritter, PhD , Rich Whitworth
Readers react to the economic turmoil of the past year and look longingly forward to 2012.
Efficient Prion Removal from Gonadotropin Solutions by Nanofiltration Membranes
By Paolo Caccia , Luca Angiolini , Renato Lorenzi , Estelle Zelter
Can a nanofiltration process be leveraged for removal of prions?
Methods for the Automated Manufacturing of an Autologous Dendritic-Cell Immunotherapy
By Tamara T. Monesmith
The author describes automated equipment that uses functionally closed disposables.
Guest Editorial
Supporting Innovation Requires Consistency and Vision
By John Castellani
Political leaders need to consider the impact of the biopharmaceutical industry on the economy.
Regulatory Beat
FDA Revamps to Meet New Challenges
By Jill Wechsler
Added responsibilities and outside concerns prompt overhaul of agency's structure.
Perspectives on Outsourcing
Troublesome Signs for Bio/Pharmaceutical R&D
By Jim Miller
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Final Word
The Case for Pediatric Exclusivity
By Christopher Milne
Reauthorization of pediatric exclusivity provisions looms in 2012 and debates begin anew.

ADVERTISEMENT

ADVERTISEMENT

Click here